Home > > > Report Detail

Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding, Major Deals, 35 Company Profiles and Recent Developments - Forecast to 2027

Publisher Name :
Date: 10-Sep-2020
No. of pages: 472

The global liquid biopsy market is expected to reach nearly US$ 8.2 Billion by 2027. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. Liquid biopsy aids in planning the required treatment and also check for treatment effectiveness as well as repeated occurrence of tumor during and after the course of cancer treatment. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization of new lesions, drug & therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.

The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years. Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement & regulation scenario.

Recent Developments


  • In June 2020, NeoGenomics, Inc. announced the launch of three liquid biopsy tests for advanced non-small cell lung cancer, all solid tumor types (pan-cancer), and certain breast cancer cases.

  • In June 2020, Guardant Health presented new data demonstrating that its LUNAR-2 liquid biopsy is a highly sensitive test that can detect early-stage colorectal cancer.

  • In January 2020, Personal Genome Diagnostics Inc. partnered with Eisai Co., Ltd. to develop a comprehensive liquid biopsy biomarker discovery solution for oncology

  • In November 2019, Lucence Diagnostics Pte Ltd, a genomic medicine company based in Singapore, raised US$ 20 Million in Series A funding.

  • In June 2019, Saga Diagnostics, a Lund, Sweden based company raised US$ 4.1 Million in a financing round from Hadean Ventures.

  • In February 2019, MDxHealth SA signed an exclusive distribution agreement with LifeLabs to make SelectMDx, the Company’s non-invasive liquid biopsy prostate cancer test, available in Canada

  • In August 2018, Bio-Techne Corporation completed its acquisition of Exosome Diagnostics, Inc.


Global Liquid Biopsy Market & Forecast - by Circulating Biomarker


  • Based on circulating biomarkers, the global liquid biopsy market is being dominated by Circulating Tumor Cells (CTCs).

  • The circulating tumor DNA (ctDNA) is the 2nd largest segment of the liquid biopsy market.

  • The cell free DNA (cfDNA) is the third largest segment of the liquid biopsy market.

  • The extracellular vesicles (EVs) segment is the fastest growing segment during the forecast period.


Global Liquid Biopsy Market & Forecast - by Product


  • The global liquid biopsy market, by product, is being dominated by Kits and Consumables.

  • The instruments segment is likely to witness highest growth in the global liquid biopsy market.

  • The services segment captured least share of the liquid biopsy market.


Global Liquid Biopsy Market & Forecast - by Application


  • The global liquid biopsy market, by application, is being dominated by oncology application.

  • Lung cancer and breast cancer accounts for largest share of the liquid biopsy oncology market.

  • The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.


Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application


  • On the basis of clinical application, the therapy selection segment is expected to account for largest share of the liquid biopsy market throughout the forecasting period.

  • Treatment monitoring captured second highest share of the liquid biopsy market in 2019, being followed by the early cancer screening application.

  • Recurrence monitoring captured least share of the liquid biopsy market.


Global Liquid Biopsy Market & Forecast - by End User


  • In 2019, Reference laboratories captured largest share of the global liquid biopsy market.

  • Hospital and Physician laboratories occupied second highest share of the liquid biopsy market in 2019, being followed by Academic and Research Centers.


Global Liquid Biopsy Market & Forecast - by Sample Type


  • Blood is the most widely used sample type and is expected to remain the largest market during the forecasting period as well.

  • The urine sample segment is anticipated to witness noticeable growth throughout the forecast period.


Liquid Biopsy Market & Forecast - Regional Analysis


  • North America accounted for largest share of the global liquid biopsy market in 2019, followed by Asia Pacific.

  • In North America, United States accounted for largest share of the liquid biopsy market.

  • In Europe, Germany and France are the leading market for liquid biopsy.

  • Asia pacific is likely to be the fastest growing market for liquid biopsy during the forecast period.

  • In Asia Pacific, Japan and China are the leading market for liquid biopsy.

  • Latin America is the fourth largest market for liquid biopsy, being followed by Middle East & Africa.


This report titled “Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding, Major Deals, 35 Company Profiles and Recent Developments - Forecast to 2027” provides a comprehensive assessment of the fast-evolving, high-growth Global Liquid Biopsy Market.  

This 472 Page report with 118 Figures and 7 Tables has been analyzed from 16 viewpoints:


  • Global Liquid Biopsy Market & Forecast (2015 - 2027)

  • Impact of COVID-19 on Global Liquid Biopsy Market

  • Global Liquid Biopsy Market Share & Forecast (2015 - 2027)

  • Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2015 - 2027)

  • Global Liquid Biopsy Market & Forecast - by Product (2015 - 2027)

  • Global Liquid Biopsy Market & Forecast - by Application (2015 - 2027)

  • Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types (2015 - 2027)

  • Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2015 - 2027)

  • Global Liquid Biopsy Market & Forecast - by End User (2015 - 2027)

  • Global Liquid Biopsy Market & Forecast - by Sample Type (2015 - 2027)

  • Liquid Biopsy Market & Forecast - Regional Analysis (2015 - 2027)

  • Liquid Biopsy Market Share & Forecast - Geographical Analysis (2015 - 2027)

  • Liquid Biopsy Initiatives

  • Liquid Biopsy Companies Financing Details

  • 35 Company Profiles – Recent Developments / Initiatives, Major Deals

  • Global Liquid Biopsy Market - Driving Factors & Challenges


Global Liquid Biopsy Market & Forecast - by Circulating Biomarker


  • Circulating Tumor Cells (CTCs)

  • Circulating Tumor DNA (ctDNA)

  • Cell-Free DNA (cfDNA)

  • Extracellular Vesicles (EVs)

  • Other Circulating Biomarkers


Global Liquid Biopsy Market & Forecast - by Product


  • Kits and Consumables

  • Instruments

  • Services


Global Liquid Biopsy Market & Forecast - by Application

1. Oncology Application


  • Lung Cancer

  • Breast Cancer

  • Colorectal Cancer

  • Prostate Cancer

  • Gastrointestinal Cancer

  • Leukaemia

  • Others


2. Non-Cancer Application

Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application


  • Therapy Selection

  • Treatment Monitoring

  • Early Cancer Screening

  • Recurrence Monitoring


Global Liquid Biopsy Market & Forecast - by End User


  • Reference Laboratories

  • Hospitals and Physician Laboratories

  • Academic and Research Centers

  • Other End Users


Global Liquid Biopsy Market & Forecast - by Sample Type


  • Blood Sample

  • Urine Sample

  • Other Fluids Sample


Liquid Biopsy Market & Forecast - Regional Analysis

1. North America


  • United States

  • Canada


2. Asia Pacific


  • South Korea

  • Japan

  • China

  • India

  • Australia

  • Rest of Asia Pacific


3. Europe


  • Germany

  • France

  • United Kingdom

  • Italy

  • Spain

  • Rest of Europe


4. Middle East & Africa


  • UAE

  • Saudi Arabia

  • Egypt

  • Rest of Middle East & Africa


5. Latin America

Liquid Biopsy Market - Company Profiles, Recent Developments / Initiatives, Major Deals


  • Personal Genome Diagnostics

  • Guardant Health, Inc.

  • Pathway Genomics

  • RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)

  • Cardiff Oncology (Previously Trovagene, Inc.)

  • LungLife AI (Formerly Cynvenio Biosystems, Inc.)

  • Biocept, Inc.

  • ANGLE plc

  • MDxHealth

  • Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)

  • Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)

  • Foundation Medicine, Inc

  • Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)

  • Genomic Health (Now Part of Exact Sciences Corp)

  • Myriad Genetics, Inc

  • Thermo Fisher Scientific, Inc

  • QIAGEN NV

  • Bio-Rad Laboratories, Inc

  • Menarini-Silicon Biosystems

  • GRAIL

  • NeoGenomics, Inc.

  • DiaCarta, Inc.

  • OncoCell MDx (Now Immunis.AI)

  • C2i Genomics

  • Biodesix

  • Freenome

  • Inivata

  • CellMax Life

  • Rarecyte Inc.

  • Saga Diagnostics

  • Thrive Earlier Detection Corp.

  • Lucence Diagnostics Pte Ltd

  • Karius, Inc.

  • Clinical Genomics Technologies Pty Ltd (CG)

  • Elypta


Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding, Major Deals, 35 Company Profiles and Recent Developments - Forecast to 2027

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Liquid Biopsy Market

3. Global Liquid Biopsy Market & Forecast (2015 - 2027)

4. Global Liquid Biopsy Market Share & Forecast (2015 - 2027) 
4.1 Global Liquid Biopsy Market Share & Forecast - by Circulating Biomarker
4.2 Global Liquid Biopsy Market Share & Forecast - by Product
4.3 Global Liquid Biopsy Market Share & Forecast - by Application
4.4 Global Liquid Biopsy Oncology Market Share & Forecast - by Clinical Application
4.5 Global Liquid Biopsy Oncology Market Share & Forecast - By Cancer Types
4.6 Global Liquid Biopsy Market Share & Forecast - by End User
4.7 Global Liquid Biopsy Market Share & Forecast - by Sample Type
4.8 Liquid Biopsy Market Share & Forecast - Regional Analysis
4.9 Liquid Biopsy Market Share & Forecast - Country Wise Analysis

5. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2015 - 2027) 
5.1 Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market & Forecast
5.2 Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market & Forecast
5.3 Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market & Forecast
5.4 Global Liquid Biopsy - Extracellular Vesicles (EVs) Market & Forecast
5.5 Global Liquid Biopsy - Other Circulating Biomarkers Market & Forecast

6. Global Liquid Biopsy Market & Forecast - by Product (2015 - 2027) 
6.1 Global Liquid Biopsy - Kits and Consumables Market & Forecast
6.2 Global Liquid Biopsy - Instruments Market & Forecast
6.3 Global Liquid Biopsy - Services Market & Forecast

7. Global Liquid Biopsy Market & Forecast - by Application (2015 - 2027) 
7.1 Global Liquid Biopsy - Oncology Application Market & Forecast
7.2 Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types
7.2.1 Lung Cancer Liquid Biopsy Market & Forecast
7.2.2 Breast Cancer Liquid Biopsy Market & Forecast
7.2.3 Colorectal Cancer Liquid Biopsy Market & Forecast
7.2.4 Prostate Cancer Liquid Biopsy Market & Forecast
7.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
7.2.6 Leukaemia Liquid Biopsy Market & Forecast
7.2.7 Others Liquid Biopsy Market & Forecast
7.3 Global Liquid Biopsy - Non-Cancer Application Market & Forecast

8. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2015 - 2027) 
8.1 Global Liquid Biopsy Oncology Application - Therapy Selection Market & Forecast
8.2 Global Liquid Biopsy Oncology Application - Treatment Monitoring Market & Forecast
8.3 Global Liquid Biopsy Oncology Application - Early Cancer Screening Market & Forecast
8.4 Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market & Forecast

9. Global Liquid Biopsy Market & Forecast - by End User (2015 - 2027) 
9.1 Global Liquid Biopsy - Reference Laboratories Market & Forecast
9.2 Global Liquid Biopsy - Hospitals and Physician Laboratories Market & Forecast
9.3 Global Liquid Biopsy - Academic and Research Centers Market & Forecast
9.4 Global Liquid Biopsy - Other End Users Market & Forecast

10. Global Liquid Biopsy Market & Forecast - by Sample Type (2015 - 2027)
10.1 Global Liquid Biopsy - Blood Sample Market & Forecast
10.2 Global Liquid Biopsy - Urine Sample Market & Forecast
10.3 Global Liquid Biopsy - Other Fluids Sample Market & Forecast

11. Liquid Biopsy Market & Forecast - Regional Analysis (2015 - 2027) 
11.1 North America Liquid Biopsy Market & Forecast
11.2 Asia Pacific Liquid Biopsy Market & Forecast
11.3 Europe Liquid Biopsy Market & Forecast
11.4 Latin America Liquid Biopsy Market & Forecast
11.5 Middle East & Africa Liquid Biopsy Market & Forecast

12. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2015 - 2027) 
12.1 North America Liquid Biopsy Market & Forecast
12.1.1 United States Liquid Biopsy Market & Forecast
12.1.2 Canada Liquid Biopsy Market & Forecast
12.2 Asia Pacific Liquid Biopsy Market & Forecast
12.2.1 South Korea Liquid Biopsy Market & Forecast
12.2.2 Japan Liquid Biopsy Market & Forecast
12.2.3 China Liquid Biopsy Market & Forecast
12.2.4 India Liquid Biopsy Market & Forecast
12.2.5 Australia Liquid Biopsy Market & Forecast
12.2.6 Rest of Asia Pacific Liquid Biopsy Market & Forecast
12.3 Europe Liquid Biopsy Market & Forecast
12.3.1 Germany Liquid Biopsy Market & Forecast
12.3.2 France Liquid Biopsy Market & Forecast
12.3.3 United Kingdom Liquid Biopsy Market & Forecast
12.3.4 Italy Liquid Biopsy Market & Forecast
12.3.5 Spain Liquid Biopsy Market & Forecast
12.3.6 Rest of Europe Liquid Biopsy Market & Forecast
12.4 Middle East & Africa Liquid Biopsy Market & Forecast
12.4.1 UAE Liquid Biopsy Market & Forecast
12.4.2 Saudi Arabia Liquid Biopsy Market & Forecast
12.4.3 Egypt Liquid Biopsy Market & Forecast
12.4.4 Rest of Middle East & Africa Liquid Biopsy Market & Forecast
12.5 Latin America Liquid Biopsy Market & Forecast

13. Liquid Biopsy Initiatives

14. Liquid Biopsy Companies Financing Details

15. Company Profiles
15.1 Personal Genome Diagnostics
15.1.1 Company Overview
15.1.2 Recent Developments / Initiatives
15.2 Guardant Health, Inc. 
15.2.1 Company Overview
15.2.2 Recent Developments / Initiatives
15.3 Pathway Genomics
15.3.1 Company Overview
15.3.2 Recent Developments / Initiatives
15.4 RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.) 
15.4.1 Company Overview
15.4.2 Recent Developments / Initiatives
15.5 Cardiff Oncology (Previously Trovagene, Inc.) 
15.5.1 Company Overview
15.5.2 Recent Developments / Initiatives
15.6 LungLife AI (Formerly Cynvenio Biosystems, Inc.) 
15.6.1 Company Overview
15.6.2 Recent Developments / Initiatives
15.7 Biocept, Inc. 
15.7.1 Company Overview
15.7.2 Recent Developments / Initiatives
15.8 ANGLE plc
15.8.1 Company Overview
15.8.2 Recent Developments / Initiatives
15.9 MDxHealth
15.9.1 Company Overview
15.9.2 Recent Developments / Initiatives
15.10 Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd) 
15.10.1 Company Overview
15.10.2 Recent Developments / Initiatives
15.11 Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation) 
15.11.1 Company Overview
15.11.2 Recent Developments / Initiatives
15.12 Foundation Medicine, Inc. 
15.12.1 Company Overview
15.12.2 Recent Developments / Initiatives
15.13 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG) 
15.13.1 Company Overview
15.13.2 Recent Developments / Initiatives
15.14 Genomic Health (Now Part of Exact Sciences Corp) 
15.14.1 Company Overview
15.14.2 Recent Developments / Initiatives
15.15 Myriad Genetics, Inc. 
15.15.1 Company Overview
15.15.2 Recent Developments / Initiatives
15.16 Thermo Fisher Scientific, Inc. 
15.16.1 Company Overview
15.16.2 Recent Developments / Initiatives
15.17 QIAGEN NV
15.17.1 Company Overview
15.17.2 Recent Developments / Initiatives
15.18 Bio-Rad Laboratories, Inc. 
15.18.1 Company Overview
15.18.2 Recent Developments / Initiatives
15.19 Menarini-Silicon Biosystems
15.19.1 Company Overview
15.19.2 Recent Developments / Initiatives
15.20 GRAIL
15.20.1 Company Overview
15.20.2 Recent Developments / Initiatives
15.21 NeoGenomics, Inc. 
15.21.1 Company Overview
15.21.2 Recent Developments / Initiatives
15.22 DiaCarta, Inc. 
15.22.1 Company Overview
15.22.2 Recent Developments / Initiatives
15.23 OncoCell MDx (Now Immunis.AI) 
15.23.1 Company Overview
15.23.2 Recent Developments / Initiatives
15.24 C2i Genomics
15.24.1 Company Overview
15.25 Biodesix
15.25.1 Company Overview
15.25.2 Recent Developments / Initiatives
15.26 Freenome
15.26.1 Company Overview
15.26.2 Recent Developments / Initiatives
15.27 Inivata
15.27.1 Company Overview
15.27.2 Recent Developments / Initiatives
15.28 CellMax Life
15.28.1 Company Overview
15.28.2 Recent Developments / Initiatives
15.29 Rarecyte Inc. 
15.29.1 Company Overview
15.29.2 Recent Developments / Initiatives
15.30 Saga Diagnostics
15.30.1 Company Overview
15.30.2 Recent Developments / Initiatives
15.31 Thrive Earlier Detection Corp. 
15.31.1 Company Overview
15.31.2 Recent Developments / Initiatives
15.32 Lucence Diagnostics Pte Ltd
15.32.1 Company Overview
15.32.2 Recent Developments / Initiatives
15.33 Karius, Inc. 
15.33.1 Company Overview
15.33.2 Recent Developments / Initiatives
15.34 Clinical Genomics Technologies Pty Ltd (CG) 
15.34.1 Company Overview
15.34.2 Recent Developments / Initiatives
15.35 Elypta
15.35.1 Company Overview
15.35.2 Recent Developments / Initiatives

16. Global Liquid Biopsy Market - Driving Factors
16.1 Rising Applications of Liquid Biopsy Expected to Boost Liquid Biopsy Market
16.2 Personalized Medicine to Spur Use of Liquid Biopsy Tests in Clinical Practice
16.3 Rising Aging Population and Cancer Incidences to Drive Liquid Biopsy Market
16.4 New Liquid Biopsy Product Launches to Fuel Market Revenues
16.5 Government Funds for Refining Cancer Detection Drives the Liquid Biopsy Market Growth
16.6 Increasing Focus of Manufacturers on Research & Development Through Collaborations To bolster Growth of Liquid Biopsy Market

17. Global Liquid Biopsy Market - Challenges
17.1 Limitations in Third-Party Payer Coverage to Restrict Liquid Biopsy Market
17.2 Liquid Biopsy Clinical Utility Challenges
17.3 Unclear Regulations on Laboratory Developed Tests (LDT) for Liquid Biopsy

List of Tables

Table 4-1: By Cancer Types - Liquid Biopsy Oncology Market Share (Percent), 2015 - 2019
Table 4-2: By Cancer Types - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2020 - 2027
Table 4-3: By Region - Liquid Biopsy Market Share (Percent), 2015 - 2019
Table 4-4: By Region - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
Table 4-5: By Country - Liquid Biopsy Market Share (Percent), 2015 - 2019
Table 4-6: By Country - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
Table 15-1: Clearbridge BioMedics - Distributors in EMEA and APAC Regions

List of Figures

Figure 3-1: Global - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 3-2: Global - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 4-1: By Circulating Biomarker - Liquid Biopsy Market Share (Percent), 2015 - 2019
Figure 4-2: By Circulating Biomarker - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
Figure 4-3: By Product - Liquid Biopsy Market Share (Percent), 2015 - 2019
Figure 4-4: By Product - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
Figure 4-5: By Application - Liquid Biopsy Market Share (Percent), 2015 - 2019
Figure 4-6: By Application - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
Figure 4-7: By Clinical Application - Liquid Biopsy Oncology Market Share (Percent), 2015 - 2019
Figure 4-8: By Clinical Application - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2020 - 2027
Figure 4-9: By End User - Liquid Biopsy Market Share (Percent), 2015 - 2019
Figure 4-10: By End User - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
Figure 4-11: By Sample Type - Liquid Biopsy Market Share (Percent), 2015 - 2019
Figure 4-12: By Sample Type - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
Figure 5-1: Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market (Million US$), 2015 - 2019
Figure 5-2: Global Liquid Biopsy - Forecast for Circulating Tumor Cells (CTCs) Market (Million US$), 2020 - 2027
Figure 5-3: Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market (Million US$), 2015 - 2019
Figure 5-4: Global Liquid Biopsy - Forecast for Circulating Tumor DNA (ctDNA) Market (Million US$), 2020 - 2027
Figure 5-5: Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market (Million US$), 2015 - 2019
Figure 5-6: Global Liquid Biopsy - Forecast for Cell-Free DNA (cfDNA) Market (Million US$), 2020 - 2027
Figure 5-7: Global Liquid Biopsy - Extracellular Vesicles (EVs) Market (Million US$), 2015 - 2019
Figure 5-8: Global Liquid Biopsy - Forecast for Extracellular Vesicles (EVs) Market (Million US$), 2020 - 2027
Figure 5-9: Global Liquid Biopsy - Other Circulating Biomarkers Market (Million US$), 2015 - 2019
Figure 5-10: Global Liquid Biopsy - Forecast for Other Circulating Biomarkers Market (Million US$), 2020 - 2027
Figure 6-1: Global Liquid Biopsy - Kits and Consumables Market (Million US$), 2015 - 2019
Figure 6-2: Global Liquid Biopsy - Forecast for Kits and Consumables Market (Million US$), 2020 - 2027
Figure 6-3: Global Liquid Biopsy - Instruments Market (Million US$), 2015 - 2019
Figure 6-4: Global Liquid Biopsy - Forecast for Instruments Market (Million US$), 2020 - 2027
Figure 6-5: Global Liquid Biopsy - Services Market (Million US$), 2015 - 2019
Figure 6-6: Global Liquid Biopsy - Forecast for Services Market (Million US$), 2020 - 2027
Figure 7-1: Global Liquid Biopsy - Oncology Application Market (Million US$), 2015 - 2019
Figure 7-2: Global Liquid Biopsy - Forecast for Oncology Application Market (Million US$), 2020 - 2027
Figure 7-3: Global - Lung Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 7-4: Global - Forecast for Lung Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 7-5: Global - Breast Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 7-6: Global - Forecast for Breast Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 7-7: Global - Colorectal Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 7-8: Global - Forecast for Colorectal Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 7-9: Global - Prostate Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 7-10: Global - Forecast for Prostate Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 7-11: Global - Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 7-12: Global - Forecast for Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 7-13: Global - Leukaemia Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 7-14: Global - Forecast for Leukaemia Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 7-15: Global - Others Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 7-16: Global - Forecast for Others Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 7-17: Global Liquid Biopsy - Non-Cancer Application Market (Million US$), 2015 - 2019
Figure 7-18: Global Liquid Biopsy - Forecast for Non-Cancer Application Market (Million US$), 2020 - 2027
Figure 8-1: Global Liquid Biopsy Oncology Application - Therapy Selection Market (Million US$), 2015 - 2019
Figure 8-2: Global Liquid Biopsy Oncology Application - Forecast for Therapy Selection Market (Million US$), 2020 - 2027
Figure 8-3: Global Liquid Biopsy Oncology Application - Treatment Monitoring Market (Million US$), 2015 - 2019
Figure 8-4: Global Liquid Biopsy Oncology Application - Forecast for Treatment Monitoring Market (Million US$), 2020 - 2027
Figure 8-5: Global Liquid Biopsy Oncology Application - Early Cancer Screening Market (Million US$), 2015 - 2019
Figure 8-6: Global Liquid Biopsy Oncology Application - Forecast for Early Cancer Screening Market (Million US$), 2020 - 2027
Figure 8-7: Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market (Million US$), 2015 - 2019
Figure 8-8: Global Liquid Biopsy Oncology Application - Forecast for Recurrence Monitoring Market (Million US$), 2020 - 2027
Figure 9-1: Global Liquid Biopsy - Reference Laboratories Market (Million US$), 2015 - 2019
Figure 9-2: Global Liquid Biopsy - Forecast for Reference Laboratories Market (Million US$), 2020 - 2027
Figure 9-3: Global Liquid Biopsy - Hospitals and Physician Laboratories Market (Million US$), 2015 - 2019
Figure 9-4: Global Liquid Biopsy - Forecast for Hospitals and Physician Laboratories Market (Million US$), 2020 - 2027
Figure 9-5: Global Liquid Biopsy - Academic and Research Centers Market (Million US$), 2015 - 2019
Figure 9-6: Global Liquid Biopsy - Forecast for Academic and Research Centers Market (Million US$), 2020 - 2027
Figure 9-7: Global Liquid Biopsy - Other End Users Market (Million US$), 2015 - 2019
Figure 9-8: Global Liquid Biopsy - Forecast for Other End Users Market (Million US$), 2020 - 2027
Figure 10-1: Global Liquid Biopsy - Blood Sample Market (Million US$), 2015 – 2019
Figure 10-2: Global Liquid Biopsy - Forecast for Blood Sample Market (Million US$), 2020 - 2027
Figure 10-3: Global Liquid Biopsy - Urine Sample Market (Million US$), 2015 - 2019
Figure 10-4: Global Liquid Biopsy - Forecast for Urine Sample Market (Million US$), 2020 - 2027
Figure 10-5: Global Liquid Biopsy - Other Fluids Sample Market (Million US$), 2015 - 2019
Figure 10-6: Global Liquid Biopsy - Forecast for Other Fluids Sample Market (Million US$), 2020 - 2027
Figure 11-1: North America - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 11-2: North America - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 11-3: Asia Pacific - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 11-4: Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 11-5: Europe - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 11-6: Europe - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 11-7: Latin America - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 11-8: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 11-9: Middle East & Africa - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 11-10: Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-1: United States - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-2: United States - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-3: Canada - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-4: Canada - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-5: South Korea - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-6: South Korea - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-7: Japan - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-8: Japan - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-9: China - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-10: China - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-11: India - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-12: India - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-13: Australia - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-14: Australia - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-15: Rest of Asia Pacific - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-16: Rest of Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-17: Germany - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-18: Germany - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-19: France - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-20: France - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-21: United Kingdom - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-22: United Kingdom - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-23: Italy - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-24: Italy - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-25: Spain - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-26: Spain - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-27: Rest of Europe - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-28: Rest of Europe - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-29: UAE - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-30: UAE - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-31: Saudi Arabia - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-32: Saudi Arabia - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-33: Egypt - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-34: Egypt - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-35: Rest of Middle East & Africa - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-36: Rest of Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
Figure 12-37: Latin America - Liquid Biopsy Market (Million US$), 2015 - 2019
Figure 12-38: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027

  • Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 133
    According to our LPI (LP Information) latest study, the global Enzyme-Linked Immunosorbent Assay (ELISA) market size was valued at US$ 1609.4 million in 2023. With growing demand in downstream market, the Enzyme-Linked Immunosorbent Assay (ELISA) is forecast to a readjusted size of US$ 2163.2 million by 2030 with a CAGR of 4.3% during review period. The research report highlights the growth potential of the global Enzyme-Linked Immunosorbent Assay (ELISA) market. Enzyme-Linked Immunosorb......
  • Global Microbiological Testing of Water Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 108
    Microbiological water testing looks for indicator organisms as a sign of faecal contamination rather than testing for specific pathogens.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements,......
  • Global Microbiological Testing of Water Market Research Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 167
    Microbiological water testing looks for indicator organisms as a sign of faecal contamination rather than testing for specific pathogens.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements,......
  • Global Companion Diagnostics Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 129
    Report Overview: The Global Companion Diagnostics Market Size was estimated at USD 9608.10 million in 2022 and is projected to reach USD 22885.61 million by 2029, exhibiting a CAGR of 13.20% during the forecast period. This report provides a deep insight into the global Companion Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key......
  • Global ADME-Toxicology Testing Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: ADME-toxicology testing is the evaluation of the metabolism of a drug molecule and its toxicity in an organism. ADME describes the pharmacological changes of a drug inside a living organism. These studies are traditionally carried out in vivo or in vitro in a controlled laboratory environment. The Global ADME-Toxicology Testing Market Size was estimated at USD 8340.90 million in 2022 and is projected to reach USD 15444.41 million by 2029, exhibiting a CAGR of 9.20% d......
  • Global Companion Diagnostics Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 88
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Companion Diagnostics market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Roche Holdings - Abbott Laboratories - Thermo Fisher Scientific - Agilent Technologies - Life Technologies - GE Healthcare - Agendia......
  • Global Syphilis Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 125
    Market Overview of Global Syphilis Testing market: According to our latest research, the global Syphilis Testing market looks promising in the next 5 years. As of 2022, the global Syphilis Testing market was estimated at USD 4240.29 million, and it's anticipated to reach USD 4930.21 million in 2028, with a CAGR of 2.54% during the forecast years. A blood test for syphilis (VDRL stands for Venereal Disease Research Laboratory) that detects an antibody that is present in the bl......
  • Global Direct-to-consumer Genetic Testing Market Status and Outlook 2023-2028
    Published: 22-Nov-2023        Price: US 3160 Onwards        Pages: 144
    Direct-to-consumer genetic testing provides people access to their genetic information without necessarily involving a healthcare provider or health insurance company in the process. Dozens of companies currently offer direct-to-consumer genetic tests for a variety of purposes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment ......
  • Global Mycotoxin Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 107
    Market Overview of Global Mycotoxin Testing market: According to our latest research, the global Mycotoxin Testing market looks promising in the next 5 years. As of 2022, the global Mycotoxin Testing market was estimated at USD 1043.41 million, and it's anticipated to reach USD 1544.04 million in 2028, with a CAGR of 6.75% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Mycotoxi......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs